ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2022

Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization.

Liyang Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.